US Patent 8222249 Isoindoline compounds and methods of their use
Patent 8222249 was granted and assigned to Celgene on July, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+208 characters)
Article
Patent abstract
Provided herein are isoindoline compounds, pharmaceutical compositions comprising one or more of such compounds, and methods of their use for treating, preventing, or managing various diseases.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Alexander L. Ruchelman0
George W. Muller0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08222249 Isoindoline compounds and methods of their use US Patent 8222249 Isoindoline compounds and methods of their use
Infobox
Patent Number
082222490
Patent Number
82222490
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082222490
Date of Patent
July 17, 2012
0Patent Application Number
133593690
Date Filed
January 26, 2012
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08222249 Isoindoline compounds and methods of their use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08222249
Date of patent
July 17, 2012
Patent application number
13359369
Date Filed
January 26, 2012
Patent primary examiner
Find more entities like US Patent 8222249 Isoindoline compounds and methods of their use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
